Clinic
Safe Medical Care, PLLC.
Safe Medical Care, PLLC. was paid $941K by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 71% of everything it billed.
33Billing provider infoSAFE MEDICAL CARE, PLLC.
OZONE PARK, NY 11416
OZONE PARK, NY 11416
33aNPI1902236433assigned 11/19/2013
33bProvider typeClinic/Center
28Total paid$941K
24GClaims48,034
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New York
Rank by total paid#103 of 235
Median peer was paid$630K
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,197 | $260K | |
| 2019 | 3,960 | $47K | |
| 2020 | 5,470 | $90K | |
| 2021 | 4,843 | $129K | |
| 2022 | 6,604 | $162K | |
| 2023 | 6,148 | $151K | |
| 2024incomplete | 4,812 | $102K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 71% | 10,041 | 9,014 | $667K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 5.0% | 487 | 487 | $47K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.0% | 304 | 304 | $29K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.4% | 537 | 519 | $23K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.3% | 1,131 | 1,054 | $22K |
| 99051 | 2.2% | 3,605 | 3,167 | $21K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.6% | 1,025 | 1,008 | $15K |
| H0049 | Alcohol and/or drug screening | 1.3% | 519 | 512 | $12K |
| G0444 | Annual depression screening, 5 to 15 minutes | 1.3% | 1,058 | 1,043 | $12K |
| 92552 | 1.3% | 472 | 463 | $12K | |
| 90674 | 1.2% | 459 | 459 | $11K | |
| 99401 | 1.1% | 332 | 330 | $10K |
59 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 107 | $9K |
| H0001 | Alcohol and/or drug assessment | <1% | 333 | $7K |
| 97802 | <1% | 217 | $6K | |
| 99408 | <1% | 304 | $5K | |
| 99442 | <1% | 51 | $4K | |
| 90686 | <1% | 170 | $4K | |
| 99000 | <1% | 2,075 | $3K | |
| 90656 | <1% | 106 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,915 | $2K |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 99 | $2K |
| 95923 | <1% | 14 | $2K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,145 | $1K |
| 90756 | <1% | 77 | $1K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 63 | $1K |
| 82947 | <1% | 319 | $1K | |
| 3074F | <1% | 1,711 | $1K | |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | <1% | 46 | $1K |
| 99406 | <1% | 84 | $953.39 | |
| 93922 | <1% | 13 | $936.52 | |
| 3078F | <1% | 1,318 | $918.01 | |
| 92551 | <1% | 87 | $735.09 | |
| 90688 | <1% | 36 | $526.26 | |
| 82274 | <1% | 26 | $446.42 | |
| 82565 | <1% | 49 | $265.92 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 445 | $231.00 |
| 36410 | <1% | 15 | $216.75 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 24 | $213.84 |
| S9470 | Nutritional counseling, dietitian visit | <1% | 46 | $195.50 |
| 82948 | <1% | 75 | $195.18 | |
| 3079F | <1% | 187 | $110.00 | |
| 3075F | <1% | 58 | $100.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 2,592 | $92.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 199 | $90.50 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 2,981 | $38.50 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 708 | $24.50 |
| G9275 | Documentation that patient is a current non-tobacco user | <1% | 572 | $17.50 |
| 3008F | <1% | 4,603 | $0.16 | |
| 3292F | 0% | 118 | $0.00 | |
| 1036F | 0% | 514 | $0.00 | |
| 3044F | 0% | 32 | $0.00 | |
| 4293F | 0% | 16 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 915 | $0.00 |
| 4010F | 0% | 35 | $0.00 | |
| 4037F | 0% | 668 | $0.00 | |
| 1000F | 0% | 721 | $0.00 | |
| 3061F | 0% | 13 | $0.00 | |
| 4086F | 0% | 13 | $0.00 | |
| 1220F | 0% | 13 | $0.00 | |
| 3017F | 0% | 50 | $0.00 | |
| 3048F | 0% | 28 | $0.00 | |
| 2023F | 0% | 12 | $0.00 | |
| 1160F | 0% | 419 | $0.00 | |
| 4013F | 0% | 121 | $0.00 | |
| 4004F | 0% | 90 | $0.00 | |
| 1159F | 0% | 182 | $0.00 | |
| 3725F | 0% | 629 | $0.00 | |
| 3016F | 0% | 516 | $0.00 | |
| G9507 | Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) | 0% | 28 | $0.00 |
| 2028F | 0% | 61 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWAHID, MOHAMMED (CEO)
| Provider | Location | Paid |
|---|---|---|
| Wahid Medical PLLC | Jamaica, NY | $2.12M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.